VRTX Average Annual Return 10 Years
VRTX Average Annual Return Chart 10 Years
Growth of $10,000.00
Without Dividends Reinvested Into VRTX

Also see:
• VRTX stock yearly return 2014
• VRTX stock yearly return 2015
• VRTX stock yearly return 2016
• VRTX stock yearly return 2017
• VRTX stock yearly return 2018
• VRTX stock yearly return 2019
• VRTX stock yearly return 2020
• VRTX stock yearly return 2021
• VRTX stock yearly return 2022
• VRTX stock yearly return 2023
• VRTX YTD return
Average Annual Return Benchmarks
Compare VRTX average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
VRTX Share Performance
VRTX Average Annual Return Table 10 Years
Start date: 10/14/2014
End date: 10/11/2024
Start price/share: $104.26
End price/share: $481.71
Dividends collected/share: $0.00
Total return: 362.03%
VRTX Average Annual Return: 16.54%
Starting investment: $10,000.00
Ending investment: $46,211.51
Years: 10.00


VRTX average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals is a biotechnology company. Co. has clinical and research programs to develop treatment of cystic fibrosis. In addition, Co. has a pipeline of investigational therapies in other diseases where it is utilizing insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency, and muscular dystrophies. Co.'s marketed CF medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (tezacaftor in combination with ivacaftor), ORKAMBI (lumacaftor in combination with ivacaftor) and KALYDECO (ivacaftor). The VRTX average annual return 10 years is shown above.

The Average Annual Return on the VRTX average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether VRTX average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the VRTX average annual return calculation with any dividends reinvested as applicable (on ex-dates).
VRTX Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree VRTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Average Annual Return Peers
Vertex Pharmaceuticals (VRTX) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

VSTM Average Annual Return
VTGN Average Annual Return
VTRS Average Annual Return
VTVT Average Annual Return
VTYX Average Annual Return
VVOS Average Annual Return
VXRT Average Annual Return
VYGR Average Annual Return
VYNE Average Annual Return
WAT Average Annual Return
More Healthcare companies »

★★★★★ Based on a ranking of our entire coverage universe by highest ten year average annual return, Vertex Pharmaceuticals (VRTX) ranks in the top 25% of all stocks whose returns we have reviewed.
What has the average annual return been for VRTX over the past ten years?
✔️Accepted answer: The ten year VRTX average annual return has been 16.54%.

What start date was used in your VRTX average annual return calculation?
✔️Accepted answer: The start date was 10/14/2014.

What end date was used in your VRTX average annual return calculation?
✔️Accepted answer: The end date was 10/11/2024.

If I had invested $10,000 into VRTX ten years ago, how much would I have today?
✔️Accepted answer: Today, as of 10/11/2024, you would have $46,211.51.

What does that work out to on a total return basis?
✔️Accepted answer: The VRTX ten year total return ending 10/11/2024 works out to 362.03%.


Also see:
• VRTX stock yearly return 2014
• VRTX stock yearly return 2015
• VRTX stock yearly return 2016
• VRTX stock yearly return 2017
• VRTX stock yearly return 2018
• VRTX stock yearly return 2019
• VRTX stock yearly return 2020
• VRTX stock yearly return 2021
• VRTX stock yearly return 2022
• VRTX stock yearly return 2023
• VRTX YTD return
 

VRTX Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2024, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.